Discovery of novel pterostilbene/biphenyl tethered 5-FU based conjugates targeting colorectal cancer: synthesis, cytotoxic and ADMET modeling studies

A new series of conjugates linking 5-FU with parts of pterostilbene and biphenyl were designed, and synthesized, besides, their biological activity was assessed against human colorectal adenocarcinoma cells (SW480) and the non-malignant cell line NCM460. Novel conjugates were first screened to establish the potential at 100 µM single dose, finding two active compounds 5e and 5g that caused more than 70% inhibition. In addition, in the seven-dose screening it was observed that, although both compounds were more active than the starting molecule 3, only compound 5e was more selective toward cancer cells than the drug 5-fluorouracil (5-FU). A theoretical examination of pharmacokinetics, toxicological, and drug-like characteristics indicates that the most promising hybrid 5e, has a strong potential to progress to further preclinical studies. Our findings unequivocally showed the effectiveness of 5-FU/pterostilbene hybrids, with the 3,4,5-trimethoxyphenylsubstituted compound serving as a prototype molecule for upcoming studies that focus on new methods for treating colorectal cancer.

• Publication year

  2025

• Venue

  Medicinal Chemistry Research

• Publication date

  2025-04-15

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00044-025-03401-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A review on pyrimidine-based pharmacophore as a template for the development of hybrid drugs with anticancer potential

  2025cited by this paper
• Development of novel triconjugates fusing melatonin/isatin/N-acylhydrazone targeting colorectal cancer: design, synthesis, biological, and in silico ADME/Tox profiling

  2025cited by this paper
• Pyrimidine: A Privileged Scaffold for the Development of Anticancer Agents as Protein Kinase Inhibitors (Recent Update).

  2025cited by this paper
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• Recent Advances in Pyrimidine-Based Drugs

  2024cited by this paper
• Predicting Pharmacokinetics of Drugs Using Artificial Intelligence Tools: A Systematic Review

  2024cited by this paper
• Correlations between in vitro gastrointestinal digestion of β-galactosidase/carboxymethylchitosan-silica dosage powder and its physicochemical properties.

  2024cited by this paper
• Novel monastrol/melatonin hybrids as a new approach for colorectal cancer intervention: design, synthesis, biological activity, and drug-likeness modeling studies

  2024cited by this paper
• Recent medicinal approaches of novel pyrimidine analogs: A review

  2023cited by this paper
• The evolving role of investigative toxicology in the pharmaceutical industry

  2023cited by this paper
• Resveratrol-derived inhibitors of the E3 ubiquitin ligase PELI1 inhibit the metastasis of triple-negative breast cancer.

  2023cited by this paper
• Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases

  2023cited by this paper
• Isolation, synthesis and medicinal chemistry of biphenyl analogs – A review

  2023cited by this paper
• Dodonaea viscosa Jacq. induces cytotoxicity, antiproliferative activity, and cell death in colorectal cancer cells via regulation of caspase 3 and p53

  2023cited by this paper
• New Hybrid Scaffolds Based on 5-FU/Curcumin: Synthesis, Cytotoxic, Antiproliferative and Pro-Apoptotic Effect

  2023cited by this paper
• Escape from planarity in fragment-based drug discovery: a synthetic strategy analysis of synthetic 3D fragment libraries.

  2022cited by this paper
• Hallmarks of Cancer: New Dimensions.

  2022cited by this paper
• Natural Products as Anticancer Agents: Current Status and Future Perspectives

  2022cited by this paper
• Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells

  2022cited by this paper
• An Insight on Medicinal Attributes of Pyrimidine Scaffold: An Updated Review

  2022cited by this paper
• Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies

  2022cited by this paper
• EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment

  2022cited by this paper
• New Hybrids Based on Curcumin and Resveratrol: Synthesis, Cytotoxicity and Antiproliferative Activity against Colorectal Cancer Cells

  2021influential reference
• Chemistry and Anticancer Activity of Hybrid Molecules and Derivatives Based on 5-Fluorouracil.

  2021cited by this paper
• Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+‐activated Cl− channels

  2021cited by this paper
• Pterostilbene in Cancer Therapy

  2021cited by this paper
• Synthesis, In Silico Studies, Antiprotozoal and Cytotoxic Activities of Quinoline‐Biphenyl Hybrids

  2020cited by this paper
• Methylene‐bearing sulfur‐containing cyanopyrimidine derivatives for treatment of cancer: Part‐II

  2020cited by this paper
• Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A

  2020cited by this paper
• Synthesis and biological evaluation of benzimidazole pendant cyanopyrimidine derivatives as anticancer agents

  2020cited by this paper
• Synthesis, ADMET prediction and reverse screening study of 3,4,5-trimethoxy phenyl ring pendant sulfur-containing cyanopyrimidine derivatives as promising apoptosis inducing anticancer agents.

  2020cited by this paper
• Anti-proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF-β1/p53 signaling pathway

  2020cited by this paper
• Fsp3: A new parameter for drug-likeness.

  2020cited by this paper
• Furanchalcone–biphenyl hybrids: synthesis, in silico studies, antitrypanosomal and cytotoxic activities

  2019cited by this paper
• Resveratrol and pterostilbene: A comparative overview of their chemistry, biosynthesis, plant sources and pharmacological properties

  2019cited by this paper
• In Silico Assessment of ADME Properties: Advances in Caco-2 Cell Monolayer Permeability Modeling.

  2019cited by this paper
• Styrylcoumarin 7-SC2 induces apoptosis in SW480 human colon adenocarcinoma cells and inhibits azoxymethane-induced aberrant crypt foci formation in BALB/c mice

  2019cited by this paper
• Fuplatin: An Efficient and Low-Toxic Dual-Prodrug.

  2019cited by this paper
• Lipophilicity and hydrophobicity considerations in bio‐enabling oral formulations approaches – a PEARRL review

  2018influential reference
• ProTox-II: a webserver for the prediction of toxicity of chemicals

  2018influential reference
• Synthesis and antiproliferative activity of 3- and 7-styrylcoumarins

  2018cited by this paper
• Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer

  2018cited by this paper
• Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells

  2018cited by this paper
• Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest

  2017cited by this paper
• Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas

  2017cited by this paper
• Recent advances (2015-2016) in anticancer hybrids.

  2017cited by this paper
• Hybrid Compounds as Direct Multitarget Ligands: A Review.

  2017cited by this paper
• Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms.

  2016cited by this paper
• Synthesis and biological evaluation of novel resveratrol-oxadiazole hybrid heterocycles as potential antiproliferative agents

  2016influential reference
• Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?

  2016cited by this paper
• Synthesis of hybrid 4-deoxypodophyllotoxin-5-fluorouracil compounds that inhibit cellular migration and induce cell cycle arrest.

  2016cited by this paper
• pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures

  2015influential reference
• Efficient and selective α-bromination of carbonyl compounds with N-bromosuccinimide under microwave

  2015cited by this paper
• Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis

  2015cited by this paper
• Anti-tumor effects and cellular mechanisms of resveratrol.

  2015cited by this paper
• Studies on drug-human serum albumin binding: the current state of the matter.

  2015influential reference
• Pred‐hERG: A Novel web‐Accessible Computational Tool for Predicting Cardiac Toxicity

  2015influential reference
• Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects

  2014cited by this paper
• What does the aromatic ring number mean for drug design?

  2014influential reference
• Synthesis and anticancer activity evaluation of resveratrol–chalcone conjugates

  2014influential reference
• In-Silico Drug Design: A revolutionary approach to change the concept of current Drug Discovery Process

  2013cited by this paper
• A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas

  2013cited by this paper
• admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties

  2012cited by this paper
• The graphical representation of ADME-related molecule properties for medicinal chemists.

  2011cited by this paper
• The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types.

  2011cited by this paper
• Modeling

  2010cited by this paper
• Hybrid molecules with a dual mode of action: dream or reality?

  2008cited by this paper
• An evaluation of the implementation of the Cramer classification scheme in the Toxtree software

  2008influential reference
• Permeability for intestinal absorption: Caco-2 assay and related issues.

  2008cited by this paper
• Microwave-Assisted Organic Synthesis in the Organic Teaching Lab: A Simple, Greener Wittig Reaction.

  2007cited by this paper
• Preparation of Vinylphenols from 2- and 4-Hydroxybenzaldehydes.

  2006cited by this paper
• A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

  2006cited by this paper
• Multicomponent therapeutics for networked systems

  2005cited by this paper
• Cáncer de colon

  2005cited by this paper
• HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS

  2004cited by this paper
• In silico prediction of drug‐binding strengths to human serum albumin

  2003influential reference
• Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.

  2000cited by this paper
• BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.

  1999cited by this paper

• No citing papers are available for this paper.